Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong
Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong Reuters Sun Pharma Q2 profit plunges 36% on exceptional charges despite revenue growth The Hindu How Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) Balancing Innovation Spending and FY26 Growth? Kalkine India Sun Pharma beats Q2 revenue estimates, falls short on profit pharma.economictimes.indiatimes.com Sun Pharma Q2...
Key Takeaways
- Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong Reuters Sun Pharma Q2 profit plunges 36% on exceptional charges despite revenue growth The Hindu How Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) Balancing Innovation Spending and FY26 Growth?
- Kalkine India Sun Pharma beats Q2 revenue estimates, falls short on profit pharma.economictimes.indiatimes.com Sun Pharma Q2 profit falls 36 pc to Rs 1,989 cr; formulations, global innovative sales push revenue ThePrint
- Full details and original dispatch available below.
Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strong Reuters Sun Pharma Q2 profit plunges 36% on exceptional charges despite revenue growth The Hindu How Is Sun Pharmaceutical Industries (NSE:SUNPHARMA) Balancing Innovation Spending and FY26 Growth? Kalkine India Sun Pharma beats Q2 revenue estimates, falls short on profit pharma.economictimes.indiatimes.com Sun Pharma Q2 profit falls 36 pc to Rs 1,989 cr; formulations, global innovative sales push revenue ThePrint
Original Publisher Attribution
This summary was curated from Reuters.